Results 91 to 100 of about 37,407 (269)

Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers   +7 more
wiley   +1 more source

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak   +4 more
wiley   +1 more source

Jacob Dahl Rendtorff, Responsibility, Ethics and Legitimacy of Corporations (Copenhagen: Copenhagen Business School Press, 2009)

open access: yesNordicum-Mediterraneum, 2011
Review of Jacob Dahl Rendtorff's book Responsibility, Ethics and Legitimacy of Corporations (Copenhagen: Copenhagen Business School Press. 2009).
Maria Pia Paganelli
doaj  

Legal Analysis of Treasury Shares in Iran’s Capital Market with Emphasis on the Nature of Shares [PDF]

open access: yesتحقیقات مالی اسلامی (پیوسته), 2018
The practice of purchasing shares by the same company is forbidden according to Article 198 of the amended Commercial Code. Pursuant to Article 28 (par.
Sayyed Mohammad Aminzadeh
doaj  

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree   +9 more
wiley   +1 more source

Corporeality, Corporality, Corporeity, and Embodiment in Performing Arts

open access: yesRevista Digital do LAV
The concepts of corporeality, corporality, corporeity, and embodiment can be misunderstood and overlapped in the researches of the performing arts area, when their differences, specificities as well as encounter points are not clear to whoever decides to develop investigations addressing these matters.
openaire   +1 more source

Traveling Through Corporate Time: Inevitability and (Anti-) Corporate Narrative Form

open access: yesNANO, 2015
I argue that the trope of time travel is an essential component of the corporation’s narrative machinery. To be clear, I am not suggesting time travel as a metaphor or figure for how the corporation operates, but rather as a vital part of its narrative ...
Adam Haley
doaj  

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

CORPORATE SOCIAL RESPONSIBILITY: PERFORMANCE AND REPORTING

open access: yesSosyal Ekonomik Araştırmalar Dergisi, 2008
Şirketlerin sosyla sorumluluğu kavramı yeni değildir. Bir şirketin ana amacı en az maliyet ile en çok gelir elde etmektir. Öte taraftan etik değerlere önem veren işadamları halka ve kendilerine karşı sorumluluklarının da bilincinde olurlar.
Meltem Tumay
doaj  

Home - About - Disclaimer - Privacy